Raymond James Financial Services Advisors, Inc. Karyopharm Therapeutics Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 Apr 21, 2020	SELL	$14.38 - $27.72 $238,664 - $460,068	-16,597 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$9.23 - $19.67 $153,190 - $326,462	16,597 New	16,597 $318,000

Others Institutions Holding KPTI

# of Institutions

Shares Held

57.6M

Call Options Held

258K

Put Options Held

81.2K

Vanguard Group Inc Valley Forge, PA

7.65M
Shares

$5.59 Million
0.0% of portfolio
Eversept Partners, LP New York, NY

5.55M
Shares

$4.05 Million
0.36% of portfolio
Palo Alto Investors LP Palo Alto, CA

5.1M
Shares

$3.72 Million
0.58% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.32M
Shares

$3.15 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.17M
Shares

$3.04 Million
0.0% of portfolio

View Full List

About Karyopharm Therapeutics Inc.

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $58.3M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

More about KPTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account